Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | SPRING BK PHARMACEUTICALS IN | COM | 849431101 | 329 | 27339 | SH | DFND | 27339 | 0 | 0 | May 5th, 2022 08:00AM | May 5th, 2022 08:00AM | Spring Bank Pharmaceuticals | ||||
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | SPRING BK PHARMACEUTICALS IN | COM | 849431101 | 62 | 5117 | SH | DFND | 33 | 0 | 0 | 5117 | May 5th, 2022 08:00AM | May 5th, 2022 08:00AM | Spring Bank Pharmaceuticals | |||
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR/A | 0000948046-21-000195 | Sep 30th, 2018 12:00AM | Dec 21st, 2021 12:00AM | Dec 21st, 2021 12:00AM | DEUTSCHE BANK AG\ | 948046 | SPRING BK PHARMACEUTICALS IN | COM | 849431101 | 0 | 12 | SH | DFND | 2 | 12 | 0 | 0 | May 5th, 2022 08:00AM | May 5th, 2022 08:00AM | Spring Bank Pharmaceuticals | |||
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR/A | 0000898427-21-000006 | Sep 30th, 2019 12:00AM | Feb 12th, 2021 12:00AM | Feb 12th, 2021 12:00AM | AXA S.A. | 898427 | SPRING BK PHARMACEUTICALS IN | COM | 849431101 | 1301 | 378178 | SH | DFND | 8,2,1 | 378178 | 0 | 0 | May 4th, 2022 06:43AM | May 4th, 2022 06:43AM | Spring Bank Pharmaceuticals | |||
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR/A | 0000898427-21-000004 | Jun 30th, 2019 12:00AM | Feb 12th, 2021 12:00AM | Feb 12th, 2021 12:00AM | AXA S.A. | 898427 | SPRING BK PHARMACEUTICALS IN | COM | 849431101 | 1398 | 378845 | SH | DFND | 8,2,1 | 378845 | 0 | 0 | May 4th, 2022 06:43AM | May 4th, 2022 06:43AM | Spring Bank Pharmaceuticals | |||
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR/A | 0001567619-18-007015 | Sep 30th, 2018 12:00AM | Nov 28th, 2018 12:00AM | Nov 28th, 2018 12:00AM | Stonepine Capital Management, LLC | 1440771 | SPRING BANK PHARMACEUTICALS | COM | 849431101 | 856 | 71050 | SH | SOLE | 71050 | 0 | 0 | Dec 8th, 2021 02:50PM | Dec 8th, 2021 02:50PM | Spring Bank Pharmaceuticals | ||||
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR | 0001144204-18-060046 | Sep 30th, 2018 12:00AM | Nov 15th, 2018 12:00AM | Nov 15th, 2018 12:00AM | Sofinnova Ventures Inc | 1631134 | Spring Bank Pharmaceuticals Inc | COMM | 849431101 | 666 | 55270 | SH | OTR | 1 | 55270 | 0 | 0 | Dec 8th, 2021 01:46PM | Dec 8th, 2021 01:46PM | Spring Bank Pharmaceuticals | |||
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR | 0001144204-18-060046 | Sep 30th, 2018 12:00AM | Nov 15th, 2018 12:00AM | Nov 15th, 2018 12:00AM | Sofinnova Ventures Inc | 1631134 | Spring Bank Pharmaceuticals Inc | COMM | 849431101 | 1294 | 107422 | SH | OTR | 2 | 107422 | 0 | 0 | Dec 8th, 2021 01:46PM | Dec 8th, 2021 01:46PM | Spring Bank Pharmaceuticals | |||
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR | 0001144204-18-060046 | Sep 30th, 2018 12:00AM | Nov 15th, 2018 12:00AM | Nov 15th, 2018 12:00AM | Sofinnova Ventures Inc | 1631134 | Spring Bank Pharmaceuticals Inc | COMM | 849431101 | 325 | 26954 | SH | SOLE | 26954 | 0 | 0 | Dec 8th, 2021 01:46PM | Dec 8th, 2021 01:46PM | Spring Bank Pharmaceuticals | ||||
nasdaq:sbph | nasdaq:sbph Shareholders | 13F-HR | 0001172661-18-002110 | Sep 30th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Nov 14th, 2018 12:00AM | Alyeska Investment Group, L.P. | 1453072 | SPRING BK PHARMACEUTICALS IN | COM | 849431101 | 2410 | 200000 | SH | Call | SOLE | 1,2 | 200000 | 0 | 0 | Dec 8th, 2021 01:22PM | Dec 8th, 2021 01:22PM | Spring Bank Pharmaceuticals |